Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia (Q79235574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Giuseppe Leone

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Fiorini A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Reddiconto G

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Farina G

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Marietti S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Chiusolo P

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sica S

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

12 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

2198-2199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17039230%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404430

20 December 2019

exact match

0 references

cites work

The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404430

7 January 2021

Myelofibrosis with myeloid metaplasia: diagnosis, prognostic factors, and staging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404430

7 January 2021

A prognostic classification of myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404430

7 January 2021

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404430

7 January 2021

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404430

7 January 2021

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404430

7 January 2021

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404430

7 January 2021

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404430

7 January 2021

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404430

7 January 2021